Prevalence of Fluoroquinolone-Resistant Campylobacter Species in Iran: A Systematic Review and Meta-Analysis

Abstract EN

Background.

Campylobacter species are one of the main causes of bacterial food poisoning worldwide.

Recently, WHO reported that the emergence of fluoroquinolone-resistant Campylobacter species is becoming a public health issue around the world.

The aim of the present systematic review and meta-analysis was to evaluate the prevalence of the antimicrobial susceptibility patterns of Campylobacter species, especially fluoroquinolone-resistant strains isolated from human and animal origins in Iran.

Methods.

Using related keywords and without date and language limitations, a comprehensive literature search was conducted in PubMed, Scopus, ISI Web of Knowledge, Google Scholar, and SID to identify relevant studies on the prevalence of the antimicrobial susceptibility patterns of Campylobacter species in Iran.

Results.

A total of 34 reports (9 in Persian and 25 in English) were selected based on inclusion and exclusion criteria.

Disk diffusion, E-test, and agar dilution were common methods used for antimicrobial susceptibility testing.

The antibiotic resistance profiles of Campylobacter species against fluoroquinolones were as follows: 53.6%, 41.8%, and 0% to ciprofloxacin for C.

jejuni, C.

coli, and C.

lari, respectively, 24.3% and 25.1% to enrofloxacin for C.

jejuni and C.

coli, respectively, 59.6% and 49.2% to nalidixic acid for C.

jejuni and C.

coli, respectively, and 87.3% and 64.7% to ofloxacin for C.

jejuni and C.

coli, respectively.

Conclusion.

Our findings revealed a high prevalence of fluoroquinolone-resistant Campylobacter species in Iran.

This calls for the use of more effective antibiotics with low resistance rates including aminoglycosides, chloramphenicol, and imipenem.